Bifidobacteria-mediated immune system imprinting early in life

Bethany M. Henrick(University of Nebraska–Lincoln), Lucie Rodriguez(Science for Life Laboratory), Tadepally Lakshmikanth(Science for Life Laboratory), Christian Pou(Science for Life Laboratory), Ewa Henckel(Karolinska University Hospital), Axel Olin(Science for Life Laboratory), Jun Wang(Science for Life Laboratory), Jaromír Mikeš(Science for Life Laboratory), Ziyang Tan(Science for Life Laboratory), Yang Chen(Science for Life Laboratory), Amy M. Ehrlich(LungLife AI (United States)), Anna Karin Bernhardsson(Science for Life Laboratory), Constantin Habimana Mugabo(Science for Life Laboratory), Ylva Ambrosiani(Karolinska Institutet), Anna Gustafsson(Karolinska University Hospital), Stephanie Chew(LungLife AI (United States)), Heather K. Brown(LungLife AI (United States)), Johann Prambs(LungLife AI (United States)), Kajsa Bohlin(Karolinska University Hospital), Ryan Mitchell(LungLife AI (United States)), Mark A. Underwood(UC Davis Children's Hospital), Jennifer T. Smilowitz(University of California, Davis), J. Bruce German(University of California, Davis), Steven A. Frese(University of Nebraska–Lincoln), Petter Brodin(Karolinska University Hospital)
bioRxiv (Cold Spring Harbor Laboratory)
October 24, 2020
Cited by 60Open Access
Full Text

Abstract

SUMMARY Immune-microbe interactions early in life influence an individual’s risk of developing allergies, asthma and some autoimmune disorders. Breastfeeding helps guide the development of healthy immune-microbe relationships, in part by providing nutrients to specialized microbes that in turn benefit the host and its developing immune system. Such bacteria having co-evolved with humans are associated with reduced risks of immune mediated diseases but are increasingly rare in modern societies. Here we map an immunological sequence of events, triggered by microbial colonization that distinguish children with different gut bacterial composition. Lack of bifidobacterial species is associated with elevated markers of intestinal inflammation and immune dysregulation and in a randomized trial of breastfed infants, the infant-adapted Bifidobacterium infantis EVC001 silenced intestinal Th2 and Th17 immune responses, while inducing IFNβ, and its metabolites skew T-cell polarization in vitro , from Th2 towards Th1, suggesting a healthier immune imprinting during the first critical months of life. HIGHLIGHTS An ordered sequence of immune changes after birth, driven by microbial interactions Low gut Bifidobacterium abundance is associated with markers of intestinal inflammation Feeding B. infantis EVC001 silenced intestinal Th2 and Th17 but upregulates IFNβ B. infantis EVC001 metabolites and/or enteric cytokines skew naïve T-cell polarization towards Th1 and away from Th2


Related Papers

No related papers found

Powered by citation graph analysis